Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A Combination Trial of Copaxone plus Estriol in Relapsing Remitting Multiple Sclerosis
Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.
Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
Characterization and quantitation of aggregates and particles in interferon-β products: Potential links between product quality attributes and immunogenicity.
Neurovascular coupling in patients with relapsing-remitting multiple sclerosis.
Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment.
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.
Timing of birth and risk of multiple sclerosis: population based study.
Plasma ubiquitin?proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
[The overall assessment of the quality of the physical health of patients with multiple sclerosis after the application of physical therapy. Part 1].
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
Interferon-beta1b for the treatment of multiple sclerosis.
Drugs@FDA
Neurorehabilitation Topics in Patients with Multiple Sclerosis: From Outcome Measurements to Rehabilitation Interventions.
Fumaric acid esters prevent the NLRP3 inflammasome-mediated and ATP-triggered pyroptosis of differentiated THP-1 cells.
Motor skill learning requires active central myelination.
Cervical cord and ventricle affection in neuromyelitis optica.
Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro.
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.
Measuring participation as defined by the World Health Organization in the International Classification of Functioning, Disability and Health. Psychometric properties of the Ghent Participation Scale.
The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids.

Pages